Delivery Order SPE2DR25D3303-SPE2DR26F62A8
Award Date 11/24/25
Potential Completion Date 11/25/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic immunosuppressant medication used to treat autoimmune conditions. This firm fixed-price delivery order carries a ceiling value of $5,204.35 and is scheduled for completion by December 9, 2025. The award was made through open competition with no set-aside designation, and the product will be delivered to AmerisourceBergen's facility...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of HUMIRA Pen 40 mg/0.8 mls, a biologic medication used to treat autoimmune conditions. The contract is a firm fixed-price delivery order with a ceiling value of $1,193.97 and an ultimate completion date of November 25, 2025. This award is non-set-aside and represents a competitive procurement action. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used for immunosuppressive therapy. This firm fixed-price delivery order carries a ceiling value of $1,574.66 and is scheduled for completion by October 20, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL with a ceiling value of $1,895.53. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The delivery order is scheduled for completion by October 16, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. HUMIRA is a widely-used...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a injectable immunosuppressant medication. This firm fixed-price contract has a ceiling value of $1,565.20 and is scheduled for completion by November 6, 2025. The award represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL, a biologic medication used to treat inflammatory conditions. This is a firm fixed-price delivery order with a ceiling value of $7,553.00 and an ultimate completion date of September 23, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at the contractor's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $9,205.44 to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on December 8, 2025, with an ultimate completion date of December 9, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. HUMIRA is a prescription immunosuppressant medication used to treat various autoimmune conditions,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls, a pharmaceutical product used to treat autoimmune conditions. This firm fixed-price delivery order carries a ceiling value of $1,210.98 and is scheduled for completion by November 21, 2025. The contract represents a non-set-aside award, indicating it was competitively awarded to AmerisourceBergen based on its demonstrated capability to meet...
- The Defense Logistics Agency awarded a $2,387.94 delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mL on November 13, 2025, with an ultimate completion date of November 14, 2025. The contract employs firm fixed price pricing with no set-aside designation, indicating competitive award selection. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a $36,664.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (CF) Pen 40 mg/0.4 mls, a biologic immunosuppressant medication used to treat autoimmune conditions. Awarded on November 18, 2025, with an ultimate completion date of November 19, 2025, this delivery order carries no set-aside designation and was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...